TipRanks
Advertisement
Advertisement

CAMRF Stock Latest News

Camurus Sets Nomination Committee and Timetable for 2027 AGM
Company AnnouncementsCamurus Sets Nomination Committee and Timetable for 2027 AGM
1M ago
Camurus’ Acromegaly Drug CAM2029 Resubmission Accepted by U.S. FDA
PremiumCompany Announcements
Camurus’ Acromegaly Drug CAM2029 Resubmission Accepted by U.S. FDA
3M ago
Camurus AB Earnings Call Highlights Growth And Risks
PremiumCompany Announcements
Camurus AB Earnings Call Highlights Growth And Risks
3M ago
Camurus Delivers Record Product Sales and Strengthens Cash While Deepening Lilly Collaboration
PremiumCompany Announcements
Camurus Delivers Record Product Sales and Strengthens Cash While Deepening Lilly Collaboration
3M ago
Camurus AB (CAMRF) Q2 Earnings Cheat Sheet
PremiumPre-Earnings
Camurus AB (CAMRF) Q2 Earnings Cheat Sheet
3M ago
Camurus Boosts Share Count to Support Employee Incentive Plan
PremiumCompany AnnouncementsCamurus Boosts Share Count to Support Employee Incentive Plan
4M ago
Camurus hit by FDA manufacturing setback on U.S. acromegaly drug filing
Premium
Company Announcements
Camurus hit by FDA manufacturing setback on U.S. acromegaly drug filing
5M ago
Camurus Targets Real‑World Evidence in New Acromegaly Study With Octreotide Depot
Premium
Company Announcements
Camurus Targets Real‑World Evidence in New Acromegaly Study With Octreotide Depot
5M ago
CAMRF
Camurus announces expansion of collaboration with Eli Lilly
PremiumThe Fly
Camurus announces expansion of collaboration with Eli Lilly
5M ago
LLY
Camurus Wins Lilly Option Exercise, Extending Long-Acting Cardiometabolic Drug Deal
PremiumCompany Announcements
Camurus Wins Lilly Option Exercise, Extending Long-Acting Cardiometabolic Drug Deal
5M ago
Camurus Repurchases Series C Shares to Fund Long-Term Incentive Plan
PremiumCompany Announcements
Camurus Repurchases Series C Shares to Fund Long-Term Incentive Plan
5M ago
Camurus AGM Backs Board, Withholds Dividend and Approves New Performance Share Plan
PremiumCompany Announcements
Camurus AGM Backs Board, Withholds Dividend and Approves New Performance Share Plan
5M ago
Camurus Holds Course on 2026 Outlook Despite Softer Q1 Sales
PremiumCompany AnnouncementsCamurus Holds Course on 2026 Outlook Despite Softer Q1 Sales
6M ago
Camurus Targets Severe Diseases With Long-Acting Drug Innovations
Premium
Company Announcements
Camurus Targets Severe Diseases With Long-Acting Drug Innovations
6M ago
Camurus calls 2026 AGM with capital measures and new incentive plan on agenda
Premium
Company Announcements
Camurus calls 2026 AGM with capital measures and new incentive plan on agenda
6M ago
Camurus Expands Share Capital After Employee Stock Option Exercises
PremiumCompany Announcements
Camurus Expands Share Capital After Employee Stock Option Exercises
7M ago
Camurus Expands Share Capital After Employee Stock Option Exercises
PremiumCompany Announcements
Camurus Expands Share Capital After Employee Stock Option Exercises
8M ago
Camurus Strengthens Executive Team With New Corporate Development Chief
PremiumCompany Announcements
Camurus Strengthens Executive Team With New Corporate Development Chief
8M ago
Camurus AB Earnings Call: Growth, FX and U.S. Push
PremiumCompany Announcements
Camurus AB Earnings Call: Growth, FX and U.S. Push
8M ago
Camurus Posts Strong 2025 Earnings, Expands Long-Acting Endocrine Portfolio
PremiumCompany AnnouncementsCamurus Posts Strong 2025 Earnings, Expands Long-Acting Endocrine Portfolio
8M ago
CAMRF Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
CAMRF Upcoming Earnings Report: What to Expect?
9M ago
Camurus announces FDA acceptance of NDA resubmission for Oclaiz
Premium
The Fly
Camurus announces FDA acceptance of NDA resubmission for Oclaiz
10M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >